Canadian Pacific Kansas City Limited Common Shares vs Revvity Inc — how do they compare? Canadian Pacific Kansas City Limited Common Shares trades at $83.86 (market cap $73.71B), while Revvity Inc trades at $152.05 (market cap $17.14B). The key difference: Canadian Pacific Kansas City Limited Common Shares is far larger — about 4.3× Revvity Inc's market cap, and Canadian Pacific Kansas City Limited Common Shares pays the higher dividend (0.91%). Which is the better fit depends on your goals.
| CP | RVTY | |
|---|---|---|
Market Cap | $73.71B | $17.14B |
Volume | 2,143,178 | 2,226,396 |
Sector | Industrials | Health |
52-Week High | $96.69 | $157.36 |
52-Week Low | $68.88 | $82.26 |
Enterprise Value | $91.14B | $19.46B |
Dividend Yield | 0.91% | 0.18% |
Typical Hold Time | — | 12 Days |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
RVTY trades at $153.60, up 0.2% today and near its 52-week high of $158.28. The stock shows bullish technical momentum with consistent earnings beats in recent quarters. Recent developments include the launch of a new diabetes detection kit in Europe and the acquisition of Human Cell Design to expand metabolic disease research capabilities. Operating cash flow improved to $628 million in 2026 from $583 million in 2025.
RVTY presents growth potential through diagnostic expansion and AI-driven demand, though premium valuation metrics pose near-term risks. The company faces margin pressures in China and competitive challenges. With 52% analyst buy ratings and strong institutional interest, the stock offers upside to the $165 high target but requires monitoring of Q3 earnings due November 3.
Trailing returns across standard periods
Latest headlines on both assets
Canadian Pacific Kansas City operates a freight railway connecting Canada, the United States, and Mexico. The company was formed through the combination of Canadian Pacific and Kansas City Southern.
Read more on CP →Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →